Latest filing published 29 Jul 2025 for Nirvana Life Sciences In., €36k.
Bruce Andrew James Clark discloses dealings in Nirvana Life Sciences In. to SEDI. Between 17 May 2023 and 25 July 2025, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 29 July 2025 came the latest disclosure, a transaction for €36k in Nirvana Life Sciences In. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations